Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom

Clinical trial NCT05557695 · RECRUITING

Trial details

NCT number: NCT05557695
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia, CLL

Start date: 2022-10-17
Primary completion: 2027-04-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.